Discontinuation of psychotropic medication: a synthesis of evidence across medication classes
Molecular Psychiatry · 2024-08 · 29 (8) · 2575-2586
DOI: 10.1038/s41380-024-02445-4 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Molecular Psychiatry, online erschienen am 19.03.2024. Verfasst von Christiaan H Vinkers und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry and Anatomy & Neurosciences, Amsterdam University Medical Center location Vrije Universiteit Amsterdam, 1081 HV, Amsterdam, …. Hauptthemen laut MEDLINE: Psychotropic Drugs, Mental Disorders, Antidepressive Agents. Die Arbeit wurde bisher 53-mal zitiert (Crossref) und nennt 159 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Pharmacotherapy is an effective treatment modality across psychiatric disorders. Nevertheless, many patients discontinue their medication at some point. Evidence-based guidance for patients, clinicians, and policymakers on rational discontinuation strategies is vital to enable the best, personalized treatment for any given patient. Nonetheless, there is a scarcity of guidelines on discontinuation strategies. In this perspective, we therefore summarize and critically appraise the evidence on discontinuation of six major psychotropic medication classes: antidepressants, antipsychotics, benzodiazepines, mood stabilizers, opioids, and stimulants. For each medication class, a wide range of topics pertaining to each of the following questions are discussed: (1) Who can discontinue (e.g., what are risk factors for relapse?); (2) When to discontinue (e.g., after 1 year or several years of antidepressant use?); and (3) How to discontinue (e.g., what’s the efficacy of dose reduction compared to full cessation and interventions to mitigate relapse risk?). We thus highlight how comparing the evidence across medication classes can identify knowledge gaps, which may pave the way for more integrated research on discontinuation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Psychiatry and Anatomy & Neurosciences, Amsterdam University Medical Center location Vrije Universiteit Amsterdam, 1081 HV, Amsterdam, The Netherlands. c.vinkers@amsterdamumc.nl.
- Amsterdam Public Health, Mental Health Program and Amsterdam Neuroscience, Mood, Anxiety, Psychosis, Sleep & Stress Program, Amsterdam, The Netherlands. c.vinkers@amsterdamumc.nl.
- GGZ inGeest Mental Health Care, Amsterdam, The Netherlands. c.vinkers@amsterdamumc.nl.
- Department of Psychiatry, Amsterdam Neuroscience and Amsterdam Public Health, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.
- Department of Psychiatry, Radboudumc, Radboud University, Nijmegen, The Netherlands.
- Donders Institute for Brain, Cognition and Behavior, Radboud University, Nijmegen, The Netherlands.
ORCID-Profile: Christiaan H Vinkers, Ralph W Kupka, Henricus G Ruhé, Sameer Jauhar, Josep A Ramos-Quiroga, Eduard Vieta, Jurjen J Luykx
Zitieren
APA
Vinkers, C. H., Kupka, R. W., Penninx, B. W., Ruhé, H. G., van Gaalen, J. M., van Haaren, P. C. F., Schellekens, A. F. A., Jauhar, S., Ramos-Quiroga, J. A., Vieta, E., Tiihonen, J., Veldman, S. E., Veling, W., Vis, R., de Wit, L. E., & Luykx, J. J. (2024). Discontinuation of psychotropic medication: a synthesis of evidence across medication classes. Molecular Psychiatry, 29(8), 2575-2586. https://doi.org/10.1038/s41380-024-02445-4
Vancouver
Vinkers CH, Kupka RW, Penninx BW, Ruhé HG, van Gaalen JM, van Haaren PCF, et al. Discontinuation of psychotropic medication: a synthesis of evidence across medication classes. Molecular Psychiatry. 2024;29(8):2575-2586. doi:10.1038/s41380-024-02445-4
BibTeX
@article{Vinkers2024,
author = {Vinkers, Christiaan H and Kupka, Ralph W and Penninx, Brenda W and Ruhé, Henricus G and van Gaalen, Jakob M and van Haaren, Paul C F and Schellekens, Arnt F A and Jauhar, Sameer and Ramos-Quiroga, Josep A and Vieta, Eduard and Tiihonen, Jari and Veldman, Stijn E and Veling, Wim and Vis, Roeland and de Wit, Laura E and Luykx, Jurjen J},
title = {Discontinuation of psychotropic medication: a synthesis of evidence across medication classes},
journal = {Molecular Psychiatry},
year = {2024},
volume = {29},
number = {8},
pages = {2575--2586},
doi = {10.1038/s41380-024-02445-4}
}
EUVIMED